Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (DEFICIT)

v3.24.1.u1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Common Stock
Class C Common Stock
Additional Paid-In Capital
Accumulated Deficit
Non-Controlling Interest
Beginning balance (in shares) at Dec. 31, 2022   57,661,274 153,899,025 0      
Beginning balance at Dec. 31, 2022 $ 95,936 $ 5 $ 16 $ 0 $ 129,508 $ (103,733) $ 70,140
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Equity-based compensation 2,506       2,287   219
Common Unit redemption (in shares)   742,583 (742,583)        
Common Unit redemption 0       299   (299)
Employee stock purchase plan (in shares)   59,521          
Employee stock purchase plan 305       305    
Net income (loss) (17,321)         (4,800) (12,521)
Ending balance (in shares) at Mar. 31, 2023   58,463,378 153,156,442 0      
Ending balance at Mar. 31, 2023 81,426 $ 5 $ 16 $ 0 132,399 (108,533) 57,539
Beginning balance (in shares) at Dec. 31, 2023   65,637,806 146,484,989 0      
Beginning balance at Dec. 31, 2023 46,508 $ 6 $ 15 $ 0 133,728 (120,478) 33,237
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Equity-based compensation 1,952       612   1,340
Common Unit redemption (in shares)   1,405,124 (1,405,124)        
Common Unit redemption 0       (42)   42
Employee stock purchase plan (in shares)   63,832          
Employee stock purchase plan 251       251    
Vesting of stock awards, net of shares withheld for taxes (in shares)   28,235          
Vesting of stock awards, net of shares withheld for taxes (30)       (30)    
Net income (loss) 1,855         548 1,307
Ending balance (in shares) at Mar. 31, 2024   67,134,997 145,079,865 0      
Ending balance at Mar. 31, 2024 $ 50,536 $ 6 $ 15 $ 0 $ 134,519 $ (119,930) $ 35,926